sunmark

Manufacturer
Strategic Sourcing Services LLC | Sun Pharma Canada Inc.
Effective date
2025-07-21
Label type
HUMAN OTC DRUG LABEL
Version
6
Source
full-release
Hydrated at
2026-06-01 01:08:04

Label at a glance#

Productsunmark Clotrimazole 3
Active ingredientCLOTRIMAZOLE
Label structure10 sections

Dosage and administration

before using this product read the enclosed educational brochure for complete directions and information adults and children 12 years of age and over: vaginal cream: insert one applicatorful of cream into the vagina at bedtime for 3 days in a row. Throw applicator away after use. external cream: use the same tube of cream if you have itching and irritation on the skin outside the vagina. Squeeze a small amount of ...

Storage and handling

To open: unscrew cap, use pointed end on cap to puncture seal do not use if carton is opened safety sealed: the tube opening should be sealed. If the seal has been punctured or is not visible, do not use the product. store between 20° to 25°C (68° to 77°F) see flap of carton or crimp of tube for lot number and expiration date

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

OTC - ACTIVE INGREDIENT SECTION

OTC - PURPOSE SECTION

Active ingredientsPurpose
Clotrimazole USP 2% (100 mg in each applicatorful)Vaginal Antifungal
Clotrimazole USP 2% (external cream)Vaginal Antifungal

Use

INDICATIONS & USAGE SECTION

  • treats vaginal yeast infections
  • relieves external itching and irritation due to a vaginal yeast infection

Warnings

WARNINGS SECTION

For vaginal use only

OTC - DO NOT USE SECTION

Do not use if you have never had a vaginal yeast infection diagnosed by a doctor

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

  • vaginal itching and discomfort for the first time
  • lower abdominal, back or shoulder pain, fever, chills, nausea, vomiting, or foul-smelling vaginal discharge. You may have a more serious condition.
  • vaginal yeast infections often (such as once a month or 3 in 6 months). You could be pregnant or have a serious underlying medical cause for your symptoms, including diabetes or a weakened immune system.
  • been exposed to the human immunodeficiency virus (HIV) that causes AIDS

When using this product

OTC - WHEN USING SECTION

  • do not use tampons, douches, spermicides, or other vaginal products. Condoms and diaphragms may be damaged and fail to prevent pregnancy or sexually transmitted diseases (STDs).
  • do not have vaginal intercourse
  • mild increase in vaginal burning, itching or irritation may occur
  • if you do not get complete relief ask a doctor before using another product

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • symptoms do not get better in 3 days
  • symptoms last more than 7 days
  • you get a rash or hives, abdominal pain, fever, chills, nausea, vomiting, or a foul-smelling vaginal discharge

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding,ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.If swallowed, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • before using this product read the enclosed educational brochure for complete directions and information
  • adults and children 12 years of age and over:
    • vaginal cream:insert one applicatorful of cream into the vagina at bedtime for 3 days in a row. Throw applicator away after use.
    • external cream:use the same tube of cream if you have itching and irritation on the skin outside the vagina. Squeeze a small amount of cream onto your fingertip. Apply to itchy, irritated skin outside the vagina. Use 2 times daily for up to 7 days as needed.
  • children under 12 years of age: ask a doctor

Other information

STORAGE AND HANDLING SECTION

  • To open: unscrew cap, use pointed end on cap to puncture seal
  • do not use if carton is opened
  • safety sealed:the tube opening should be sealed. If the seal has been punctured or is not visible, do not use the product.
  • store between 20° to 25°C (68° to 77°F)
  • see flap of carton or crimp of tube for lot number and expiration date

Inactive ingredients

INACTIVE INGREDIENT SECTION

benzyl alcohol, cetostearyl alcohol, cetyl esters wax, 2-octyldodecanol, polysorbate-60, purified water, and sorbitan monostearate

Questions or comments?

OTC - QUESTIONS SECTION

Call toll-free, 1-888-827-6222,for our 24 hour automated response system.

SPL UNCLASSIFIED SECTION

Distributed by McKesson
One Post Street
San Francisco, CA 94104

PRINCIPAL DISPLAY PANEL - 21 g Tube Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

sunmark ®

clotrimazole 3

Clotrimazole Vaginal Cream USP (2%)
Vaginal Antifungal

Cures Most Vaginal Yeast Infections

3 DAY TREATMENT

One 21 g (0.74 oz) Tube Of Clotrimazole Vaginal Cream USP (2%)
& 3 Disposable Applicators

Principal Display Panel - 21 g Tube Carton
Principal Display Panel - 21 g Tube Carton

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
199603clotrimazole 2 % Vaginal CreamPSN6
199603clotrimazole 20 MG/ML Vaginal CreamSCD6
199603clotrimazole 2 % Vaginal CreamSY6

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
CLOTRIMAZOLE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
b64d2752-34ef-378a-1f4f-8bff32b0d1aeProduct name420250626
cb7783e0-feaa-7e56-fb3b-d43b6efa77c9Product name220250121
f31c883b-7ebf-1c60-f3b6-4ba41e8ff7a6Product name220151106
9869efd7-d6dd-0665-5b67-53adbe6ef15eProduct name120140508
f5395dd2-4395-d8c6-3477-8c2d4a2f951cProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
49348-379-54sunmarkClotrimazole 31 in 1 CARTONCREAM16
49348-379-54sunmarkClotrimazole 321 g in 1 TUBE, WITH APPLICATORCREAM216

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
49348-379-54GM - Gram49348-3792028325d-08d0-4d4b-9897-815e8d89316412013-03-03

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
ClotrimazoleACTIVE INGREDIENTG07GZ97H651
ClotrimazoleACTIVE MOIETYG07GZ97H651
benzyl alcoholINACTIVE INGREDIENTLKG8494WBH1
cetostearyl alcoholINACTIVE INGREDIENT2DMT128M1S1
cetyl esters waxINACTIVE INGREDIENTD072FFP9GU1
octyldodecanolINACTIVE INGREDIENT461N1O614Y1
polysorbate 60INACTIVE INGREDIENTCAL22UVI4M1
sorbitan monostearateINACTIVE INGREDIENTNVZ4I0H58X1
waterINACTIVE INGREDIENT059QF0KO0R1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
49348-37949348-379-54

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 2 · 97 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
benzyl alcoholBENZYL ALCOHOLLKG8494WBHSPRAY / NASAL5 mgExact identifier — unii candidate
50 equally ranked IID candidates
benzyl alcoholBENZYL ALCOHOLLKG8494WBHINJECTION, SOLUTION / INTRAMUSCULAR500 mgExact identifier — unii candidate
50 equally ranked IID candidates
benzyl alcoholBENZYL ALCOHOLLKG8494WBHINJECTION, SUSPENSION / INTRA-ARTICULAR40 mgExact identifier — unii candidate
50 equally ranked IID candidates
polysorbate 60POLYSORBATE 60CAL22UVI4MGUM, CHEWING / BUCCAL5 mgExact identifier — unii candidate
13 equally ranked IID candidates
polysorbate 60POLYSORBATE 60CAL22UVI4MLOTION / TOPICAL5 %w/wExact identifier — unii candidate
13 equally ranked IID candidates
octyldodecanolOCTYLDODECANOL461N1O614YSYSTEM / TRANSDERMAL4.05 mgExact identifier — unii candidate
9 equally ranked IID candidates
polysorbate 60POLYSORBATE 60CAL22UVI4MCREAM / VAGINAL200 mgExact identifier — unii candidate
13 equally ranked IID candidates
octyldodecanolOCTYLDODECANOL461N1O614YFILM / TRANSDERMAL32.44 mgExact identifier — unii candidate
9 equally ranked IID candidates
cetostearyl alcoholCETOSTEARYL ALCOHOL2DMT128M1STABLET, EXTENDED RELEASE / ORAL800 mgExact identifier — unii candidate
9 equally ranked IID candidates
cetostearyl alcoholCETOSTEARYL ALCOHOL2DMT128M1SAEROSOL, FOAM / TOPICAL82 mgExact identifier — unii candidate
9 equally ranked IID candidates
polysorbate 60POLYSORBATE 60CAL22UVI4MCREAM / TOPICAL428 mgExact identifier — unii candidate
13 equally ranked IID candidates
benzyl alcoholBENZYL ALCOHOLLKG8494WBHINJECTION / SUBCONJUNCTIVAL252 mgExact identifier — unii candidate
50 equally ranked IID candidates
benzyl alcoholBENZYL ALCOHOLLKG8494WBHTABLET, DELAYED RELEASE / ORAL2.31 mgExact identifier — unii candidate
50 equally ranked IID candidates
benzyl alcoholBENZYL ALCOHOLLKG8494WBHSOLUTION / TOPICAL2 %w/wExact identifier — unii candidate
50 equally ranked IID candidates
benzyl alcoholBENZYL ALCOHOLLKG8494WBHSHAMPOO / TOPICAL150 mgExact identifier — unii candidate
50 equally ranked IID candidates
benzyl alcoholBENZYL ALCOHOLLKG8494WBHSOLUTION / ORAL360 mgExact identifier — unii candidate
50 equally ranked IID candidates
benzyl alcoholBENZYL ALCOHOLLKG8494WBHINJECTION, POWDER, FOR SOLUTION / INTRAVENOUS144 mgExact identifier — unii candidate
50 equally ranked IID candidates
octyldodecanolOCTYLDODECANOL461N1O614YLOTION / TOPICAL714 mgExact identifier — unii candidate
9 equally ranked IID candidates
sorbitan monostearateSORBITAN MONOSTEARATENVZ4I0H58XSPRAY / TOPICAL4.58 %w/wExact identifier — unii candidate
11 equally ranked IID candidates
sorbitan monostearateSORBITAN MONOSTEARATENVZ4I0H58XOINTMENT / TOPICALNAExact identifier — unii candidate
11 equally ranked IID candidates
benzyl alcoholBENZYL ALCOHOLLKG8494WBHINJECTION, EMULSION / SUBCUTANEOUS225 mgExact identifier — unii candidate
50 equally ranked IID candidates
benzyl alcoholBENZYL ALCOHOLLKG8494WBHINJECTION, SUSPENSION / SOFT TISSUE40 mgExact identifier — unii candidate
50 equally ranked IID candidates
sorbitan monostearateSORBITAN MONOSTEARATENVZ4I0H58XSUSPENSION / ORAL62.5 mg/5mlExact identifier — unii candidate
11 equally ranked IID candidates
polysorbate 60POLYSORBATE 60CAL22UVI4MSUPPOSITORY / RECTAL0.05 mg/mgExact identifier — unii candidate
13 equally ranked IID candidates
cetyl esters waxCETYL ESTERS WAXD072FFP9GUSUPPOSITORY / VAGINALNAExact identifier — unii candidate
5 equally ranked IID candidates
benzyl alcoholBENZYL ALCOHOLLKG8494WBHLOTION / TOPICAL4000 mgExact identifier — unii candidate
50 equally ranked IID candidates
cetyl esters waxCETYL ESTERS WAXD072FFP9GUCREAM / VAGINAL3 %w/wExact identifier — unii candidate
5 equally ranked IID candidates
sorbitan monostearateSORBITAN MONOSTEARATENVZ4I0H58XCREAM / TOPICAL429 mgExact identifier — unii candidate
11 equally ranked IID candidates
benzyl alcoholBENZYL ALCOHOLLKG8494WBHLIQUID / INTRAVENOUS1.04 %w/vExact identifier — unii candidate
50 equally ranked IID candidates
benzyl alcoholBENZYL ALCOHOLLKG8494WBHGEL / RECTAL124 mgExact identifier — unii candidate
50 equally ranked IID candidates
cetyl esters waxCETYL ESTERS WAXD072FFP9GULOTION / TOPICAL1 %w/wExact identifier — unii candidate
5 equally ranked IID candidates
sorbitan monostearateSORBITAN MONOSTEARATENVZ4I0H58XCREAM / VAGINAL100 mgExact identifier — unii candidate
11 equally ranked IID candidates
benzyl alcoholBENZYL ALCOHOLLKG8494WBHINJECTION, SOLUTION / INTRAVENOUS400 mgExact identifier — unii candidate
50 equally ranked IID candidates
sorbitan monostearateSORBITAN MONOSTEARATENVZ4I0H58XSUPPOSITORY / VAGINALNAExact identifier — unii candidate
11 equally ranked IID candidates
cetyl esters waxCETYL ESTERS WAXD072FFP9GUCREAM / TOPICAL10.3 %w/wExact identifier — unii candidate
5 equally ranked IID candidates
benzyl alcoholBENZYL ALCOHOLLKG8494WBHINJECTION, SOLUTION / INTRA-ARTICULAR23 mgExact identifier — unii candidate
50 equally ranked IID candidates
cetostearyl alcoholCETOSTEARYL ALCOHOL2DMT128M1SSUPPOSITORY / VAGINALNAExact identifier — unii candidate
9 equally ranked IID candidates
benzyl alcoholBENZYL ALCOHOLLKG8494WBHCAPSULE, EXTENDED RELEASE / ORAL1.23 mgExact identifier — unii candidate
50 equally ranked IID candidates
cetostearyl alcoholCETOSTEARYL ALCOHOL2DMT128M1SCAPSULE, EXTENDED RELEASE / ORAL9.43 mgExact identifier — unii candidate
9 equally ranked IID candidates
benzyl alcoholBENZYL ALCOHOLLKG8494WBHINJECTION / INTRACAVITARY0.01 mlExact identifier — unii candidate
50 equally ranked IID candidates
cetostearyl alcoholCETOSTEARYL ALCOHOL2DMT128M1SCREAM / VAGINAL6 mgExact identifier — unii candidate
9 equally ranked IID candidates
benzyl alcoholBENZYL ALCOHOLLKG8494WBHOINTMENT / TOPICAL2.2 %w/wExact identifier — unii candidate
50 equally ranked IID candidates
sorbitan monostearateSORBITAN MONOSTEARATENVZ4I0H58XAEROSOL, FOAM / TOPICAL0.55 %w/wExact identifier — unii candidate
11 equally ranked IID candidates
polysorbate 60POLYSORBATE 60CAL22UVI4MSUSPENSION / ORAL125 mgExact identifier — unii candidate
13 equally ranked IID candidates
benzyl alcoholBENZYL ALCOHOLLKG8494WBHINJECTION / SUBCUTANEOUS90 mgExact identifier — unii candidate
50 equally ranked IID candidates
polysorbate 60POLYSORBATE 60CAL22UVI4MEMULSION / ORAL20 mg/1mlExact identifier — unii candidate
13 equally ranked IID candidates
benzyl alcoholBENZYL ALCOHOLLKG8494WBHINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARY8.4 mgExact identifier — unii candidate
50 equally ranked IID candidates
benzyl alcoholBENZYL ALCOHOLLKG8494WBHINJECTION / INTRALESIONAL23 mgExact identifier — unii candidate
50 equally ranked IID candidates
benzyl alcoholBENZYL ALCOHOLLKG8494WBHSUPPOSITORY / VAGINALNAExact identifier — unii candidate
50 equally ranked IID candidates
benzyl alcoholBENZYL ALCOHOLLKG8494WBHINJECTION, EMULSION / INTRAMUSCULAR225 mgExact identifier — unii candidate
50 equally ranked IID candidates
polysorbate 60POLYSORBATE 60CAL22UVI4MSUSPENSION / TOPICAL123 mgExact identifier — unii candidate
13 equally ranked IID candidates
benzyl alcoholBENZYL ALCOHOLLKG8494WBHINJECTION / INTRA-ARTICULAR1 %w/vExact identifier — unii candidate
50 equally ranked IID candidates
polysorbate 60POLYSORBATE 60CAL22UVI4MAEROSOL, FOAM / TOPICAL31 mgExact identifier — unii candidate
13 equally ranked IID candidates
benzyl alcoholBENZYL ALCOHOLLKG8494WBHINJECTION / ENDOTRACHEAL54 mgExact identifier — unii candidate
50 equally ranked IID candidates
sorbitan monostearateSORBITAN MONOSTEARATENVZ4I0H58XSOLUTION / TOPICALNAExact identifier — unii candidate
11 equally ranked IID candidates
benzyl alcoholBENZYL ALCOHOLLKG8494WBHGEL / VAGINAL100 mgExact identifier — unii candidate
50 equally ranked IID candidates
polysorbate 60POLYSORBATE 60CAL22UVI4MOINTMENT / TOPICAL2 %w/wExact identifier — unii candidate
13 equally ranked IID candidates
sorbitan monostearateSORBITAN MONOSTEARATENVZ4I0H58XLOTION / TOPICAL89 mgExact identifier — unii candidate
11 equally ranked IID candidates
cetostearyl alcoholCETOSTEARYL ALCOHOL2DMT128M1SLOTION / TOPICAL3627 mgExact identifier — unii candidate
9 equally ranked IID candidates
benzyl alcoholBENZYL ALCOHOLLKG8494WBHCAPSULE / ORAL450 mgExact identifier — unii candidate
50 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N021143-001TRIVAGIZOLE 3CLOTRIMAZOLE2%CREAM / VAGINAL2000-04-12

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 45 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10N021143-001TRIVAGIZOLE 32%CREAM / VAGINAL2000-04-12d4dbc9d85df4…
2026-10-15 13:18:302026-09N021143-001TRIVAGIZOLE 32%CREAM / VAGINAL2000-04-12c2088c7a36db…
2026-09-14 22:38:342026-08N021143-001TRIVAGIZOLE 32%CREAM / VAGINAL2000-04-1284e616aacf4f…
2026-08-18 06:07:402026-07N021143-001TRIVAGIZOLE 32%CREAM / VAGINAL2000-04-12caaa826d4ba7…
2026-02-19 14:30 UTC2026-02N021143-001TRIVAGIZOLE 32%CREAM / VAGINAL2000-04-12011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021143-001TRIVAGIZOLE 32%CREAM / VAGINAL2000-04-1231067a03dcf5…
2025-08-23 18:47 UTC2025-08N021143-001TRIVAGIZOLE 32%CREAM / VAGINAL2000-04-126a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021143-001TRIVAGIZOLE 32%CREAM / VAGINAL2000-04-12fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N021143-001TRIVAGIZOLE 32%CREAM / VAGINAL2000-04-12b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N021143-001TRIVAGIZOLE 32%CREAM / VAGINAL2000-04-1203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N021143-001TRIVAGIZOLE 32%CREAM / VAGINAL2000-04-122680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N021143-001TRIVAGIZOLE 32%CREAM / VAGINAL2000-04-125bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N021143-001TRIVAGIZOLE 32%CREAM / VAGINAL2000-04-12d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N021143-001TRIVAGIZOLE 32%CREAM / VAGINAL2000-04-12d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N021143-001TRIVAGIZOLE 32%CREAM / VAGINAL2000-04-1279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N021143-001TRIVAGIZOLE 32%CREAM / VAGINAL2000-04-12301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N021143-001TRIVAGIZOLE 32%CREAM / VAGINAL2000-04-121e350fbaab3a…
2024-05-31 18:47 UTC2024-05N021143-001TRIVAGIZOLE 32%CREAM / VAGINAL2000-04-128072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N021143-001TRIVAGIZOLE 32%CREAM / VAGINAL2000-04-125c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N021143-001TRIVAGIZOLE 32%CREAM / VAGINAL2000-04-125d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N021143-001TRIVAGIZOLE 32%CREAM / VAGINAL2000-04-124b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N021143-001TRIVAGIZOLE 32%CREAM / VAGINAL2000-04-1274a2ff9319b5…
2022-03-09 01:35 UTC2022-03N021143-001TRIVAGIZOLE 32%CREAM / VAGINAL2000-04-12bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N021143-001TRIVAGIZOLE 32%CREAM / VAGINAL2000-04-12782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N021143-001TRIVAGIZOLE 32%CREAM / VAGINAL2000-04-1287673890dc5c…
2021-03-12 10:30 UTC2021-03N021143-001TRIVAGIZOLE 32%CREAM / VAGINAL2000-04-125aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N021143-001TRIVAGIZOLE 32%CREAM / VAGINAL2000-04-128869cabd3fbd…
2020-11-12 02:37 UTC2020-11N021143-001TRIVAGIZOLE 32%CREAM / VAGINAL2000-04-12c0c555d07b60…
2019-12-14 00:12 UTC2019-12N021143-001TRIVAGIZOLE 32%CREAM / VAGINAL2000-04-123f01610625f2…
2019-09-15 20:21 UTC2019-09N021143-001TRIVAGIZOLE 32%CREAM / VAGINAL2000-04-12b00525d2431f…
2019-07-19 19:46 UTC2019-07N021143-001TRIVAGIZOLE 32%CREAM / VAGINAL2000-04-12ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N021143-001TRIVAGIZOLE 32%CREAM / VAGINAL2000-04-126a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N021143-001TRIVAGIZOLE 32%CREAM / VAGINAL2000-04-121c564ffb4f44…
2023-12-20 04:57 UTC2023-12N021143-001TRIVAGIZOLE 32%CREAM / VAGINAL2000-04-12ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N021143-001TRIVAGIZOLE 32%CREAM / VAGINAL2000-04-12a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N021143-001TRIVAGIZOLE 32%CREAM / VAGINAL2000-04-129b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N021143-001TRIVAGIZOLE 32%CREAM / VAGINAL2000-04-12a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N021143-001TRIVAGIZOLE 32%CREAM / VAGINAL2000-04-123f0d92c62455…
2023-05-13 08:27 UTC2023-05N021143-001TRIVAGIZOLE 32%CREAM / VAGINAL2000-04-12053a50430f4f…
2023-01-26 05:58 UTC2023-01N021143-001TRIVAGIZOLE 32%CREAM / VAGINAL2000-04-123bdfa0b2c4d7…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
3a76faa8-aa42-362d-e063-6294a90a2eab0bc5d91a-c4ea-4fe9-80e0-6f76aa073e7b2025-07-21WarningsExact identifier
spl id: 3a76faa8-aa42-362d-e063-6294a90a2eab
spl set id: 0bc5d91a-c4ea-4fe9-80e0-6f76aa073e7b

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.